Global Interventional Cardiology and Peripheral Vascular Devices Market by Product Type (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, & Accessories), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, & Other End-Use), and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Interventional Cardiology and Peripheral Vascular Devices Market Overview:

The global Interventional Cardiology and Peripheral Vascular Devices Market is projected to be USD 22,866.1 Mn in 2020 to reach USD 41,431.8 Mn by 2030 at a CAGR of 5.4%.

Interventional cardiology is a branch of cardiology based on endovascular catheter technologies to treat structural heart diseases. To treat arrhythmia & other cardiovascular diseases, the healthcare industry includes equipment like cardiovascular surgery equipment, cardiac rhythm management (CRM) equipment, interventional cardiology equipment, peripheral vascular equipment, electrophysiological equipment, and others used in surgery. Peripheral vascular disease (PVD) narrows arteries outside the brain and heart.

High blood pressure, diabetes, obesity, and smoking are some of the risk factors associated with PVD growth. Peripheral vascular devices are used to treat blocked arteries and remove accumulated plaque. Peripheral vascular stents, angioplasty balloon catheters, guidewires, and aortic stents are the most commonly used equipment for PVD treatment. Major interventional cardiology procedures for treating chronic heart diseases include angioplasty stents, atherectomy, embolization protection, and balloon angioplasty.

Global Interventional Cardiology and Peripheral Vascular Devices Market Revenue (USD Mn), 2020–2030:

The increasing prevalence of chronic heart diseases such as hypertrophic cardiomyopathy, cardiac failure, & coronary artery, has increased heart patients worldwide. Increasing consumption of junk food, poor lifestyle, smoking, and drinking increases chronic heart disease risk. These factors are driving revenue growth for the interventional cardiology peripheral vascular devices market. In addition, the increasing world population, coupled with the growing geriatric population, has increased the demand for early detection of incurable diseases. The massive investment in the development of domestic manufacturing of medical devices, especially in cancer, respiratory, cardiac, and renal care segments by the government and private sectors, is expected to drive market growth in the forecasted period.

Growing technological and researchers and manufacturers focus on developing new systems with improved features, such as bioabsorbable stents, a new generation of drug-eluting balloons, and innovations in interventional cardiology and peripheral vascular devices to boost the market growth. Additionally, several companies have invested in R&D activities to develop innovative products. Such factors are expected to drive market growth.

Global Interventional Cardiology and Peripheral Vascular Devices Market Attractiveness Analysis by Butter Type, 2014–2030:

The global interventional cardiology and peripheral vascular devices market is segmented into product type, end-use, and regions. The product type segment includes angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, flow alteration devices, and accessories. The angioplasty stents segment accounts for the highest revenue share among the product type segments, owing to its increased adoption and wide use in several heart surgeries. Among the end-use segments, the hospitals account for a significant share in terms of revenue. This is due to the increase in the number of heart operations cases across the globe.

Moreover, hospitals and cardiac centers, intensive care units provide patients with reimbursement and insurance facilities. This factor is expected to support the growth of the segment. Among the regional markets, the North American market is expected to account for a significant revenue share and is projected to maintain its dominance in the global interventional cardiology and peripheral vascular devices market over the forecast period. This is due to the presence of a geriatric population in the region. In addition, most of the top key players in medical device manufacturing are located in the US which supports the market’s revenue growth.

The research report on the global Interventional Cardiology and Peripheral Vascular Devices Market includes profiles of some of the major companies such as

• Cardinal Health, Inc.,
• Abbott Laboratories,
• Medtronic Plc,
• Becton, Dickinson & Co.,
• Boston Scientific Corporation,
• B. Braun Melsungen AG,
• Terumo Corp.,
• Teleflex, Inc.,
• Biotronik SE & Co KG,
• Biosensors International Group Ltd.,
• iVascular, and others.

Global Interventional Cardiology and Peripheral Vascular Devices Market segmentation based on Product Type, End-use, and Region:

Based on Product Type

• Angioplasty Balloons
  • Normal Balloons
  • Cutting and Scoring Balloons
  • Drug-eluting Balloons
• Angioplasty Stents
  • Coronary Stent
  • Peripheral Stents
• Angioplasty Catheters
  • Angiography Catheters
  • Guiding Catheters
  • Others
• Endovascular Aneurysm Repair Stent Grafts
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
  • Thrombectomy Devices
  • Atherectomy Devices
  • Others
• Hemodynamic Flow Alteration Devices
  • Embolic Protection Devices
  • Chronic Total Occlusion Devices
• Accessories
  • Vascular Closure Devices
  • Guidewires
  • Others

Based on End-use

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other Distribution Channels

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

For the Interventional Cardiology and Peripheral Vascular Devices Market research study, the following years have been considered to estimate the market size: